Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/14/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/06/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/06/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/06/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/30/19 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
25 | |
| 04/15/19 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
70 | |
| 04/10/19 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 04/10/19 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 04/08/19 | 4/A | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/01/19 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
159 |
